The pharmaceutical big has settled the overwhelming majority of instances round its drug Zantac within the US, boosting investor confidence within the firm.
Supply hyperlink
GSK shares soar after landmark £1.68bn heartburn drug settlement
The pharmaceutical big has settled the overwhelming majority of instances round its drug Zantac within the US, boosting investor confidence within the firm.
Supply hyperlink
